Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for LH Pulse Frequency in Pubertal Girls with Hyperandrogenism
NCT03068910Phase 1Recruiting
- Sponsor
- University of Virginia
- Start
- Jul 2016
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in hyperandrogenism comparing Spironolactone First with Placebo First (2 arms). Primary endpoint: Wake Luteinizing Hormone Pulse Frequency at 2 weeks. Started Jul 2016; status: recruiting.
02
Drugs
spironolactone
03
Conditions
hyperandrogenism
Beyond the preview
Go deeper on NCT03068910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03068910.